Gadofosveset: Parameter optimization for steady-state imaging of the thoracic and abdominal vasculature

Investigative Radiology

Volumn 46, Issue 11, 2011, Pages 678-685

  Haneder, Stefan ^a   Attenberger, Ulrike I ^a   Biffar, Andreas ^b   Dietrich, Olaf ^b   Fink, Christian ^a   Schoenberg, Stefan O ^a   Michaely, Henrik J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

1.5 T; gadofosveset; magnetic resonance angiography; sequence comparison; SNR CNR; steady state

Indexed keywords

GADOFOSVESET;

ADULT; AORTA; ARTICLE; BREATH HOLDING; HUMAN; HUMAN EXPERIMENT; INFERIOR CAVA VEIN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RADIATION DOSE; SIGNAL NOISE RATIO; VASCULARIZATION;

EID: 80053605477     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e31822428ad     Document Type: Article

References (28)

1. Michaely HJ, Sourbron S, Dietrich O, et al. Functional renal MR imaging: an overview. Abdom Imaging. 2007;32:758-771. (Pubitemid 350060488)
2. Vosshenrich R, Fischer U. Contrast-enhanced MR angiography of abdominal vessels: is there still a role for angiography? Eur Radiol. 2002;12:218-230. (Pubitemid 36940050)
3. EMEA. European Public Assessment Report-Vasovist. www.emea.europa.eu. European Medicines Agency 2009. Accessed August 2009.
4. Wagner M, Rosler R, Lembcke A, et al. Whole-heart coronary magnetic resonance angiography at 1.5 Tesla: does a blood-pool contrast agent improve diagnostic accuracy? Invest Radiol. 2011;46:152-159.
5. Cornelissen SA, Prokop M, Verhagen HJ, et al. Detection of occult endoleaks after endovascular treatment of abdominal aortic aneurysm using magnetic resonance imaging with a blood pool contrast agent: preliminary observations. Invest Radiol. 2010;45:548-553.
6. Lobbes MB, Heeneman S, Passos VL, et al. Gadofosveset-enhanced magnetic resonance imaging of human carotid atherosclerotic plaques: a proof-ofconcept study. Invest Radiol. 2010;45:275-281.
7. FDA. FDA approves first imaging agent to enhance scans of blood flow. www.fda.org. US Food and Drug Administration 2008. Accessed August 2010.
8. Lauffer RB, Parmelee DJ, Dunham SU, et al. MS-325: albumin-targeted contrast agent for MR angiography. Radiology. 1998;207:529-538. (Pubitemid 28259074)
9. Rohrer M. MRI Contrast Media-Introduction and Basic Properties of the Blood Pool Agent Gadofosveset (Vasovist). In: Leiner T, Goyen M, Rohrer M, et al, eds. Clinical Blood Pool MR Imaging. Heidelberg: Springer; 2008:3-15.
10. Rohrer M, Bauer H, Mintorovitch J, et al. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol. 2005;40:715-724. (Pubitemid 41546838)
11. Caravan P, Parigi G, Chasse JM, et al. Albumin binding, relaxivity, and water exchange kinetics of the diastereoisomers of MS-325, a gadolinium(III)-based magnetic resonance angiography contrast agent. Inorg Chem. 2007;46: 6632-6639.
12. Grist TM, Korosec FR, Peters DC, et al. Steady-state and dynamic MR angiography with MS-325: initial experience in humans. Radiology. 1998; 207:539-544. (Pubitemid 28259075)
13. Bock M, Schulz J, Ueltzhoeffer S, et al. Intravascular contrast agent T1 shortening: fast T1 relaxometry in a carotid volunteer study. MAGMA. 2008;21:363-368.
14. Nikolaou K, Kramer H, Grosse C, et al. High-spatial-resolution multistation MR angiography with parallel imaging and blood pool contrast agent: initial experience. Radiology. 2006;241:861-872. (Pubitemid 46190554)
15. Hartmann M, Wiethoff AJ, Hentrich HR, et al. Initial imaging recommendations for Vasovist angiography. Eur Radiol. 2006;(16 suppl 2):B15-B23.
16. Goyen M. Gadofosveset-enhanced magnetic resonance angiography. Vasc Health Risk Manag. 2008;4:1-9. (Pubitemid 351460842)
17. Nissen JC, Attenberger UI, Fink C, et al. Thoracic and abdominal MRA with gadofosveset: influence of injection rate on vessel signal and image quality. Eur Radiol. 2009;19:1932-1938.
18. Michaely HJ, Attenberger UI, Dietrich O, et al. Feasibility of gadofosvesetenhanced steady-state magnetic resonance angiography of the peripheral vessels at 3 Tesla with Dixon fat saturation. Invest Radiol. 2008;43:635-641.
19. Dietrich O, Raya JG, Reeder SB, et al. Measurement of signal-to-noise ratios in MR images: influence of multichannel coils, parallel imaging, and reconstruction filters. J Magn Reson Imaging. 2007;26:375-385. (Pubitemid 47257737)
20. Reeder SB, Wintersperger BJ, Dietrich O, et al. Practical approaches to the evaluation of signal-to-noise ratio performance with parallel imaging: application with cardiac imaging and a 32-channel cardiac coil. Magn Reson Med. 2005;54:748-754. (Pubitemid 41233774)
21. Haacke EM, Brown RW, Thompson MR, et al. Spin Density, T1 and T2 Quantification Methods in MR Imaging. In: Magnetic Resonance Imaging: Physical Principles and Sequence Design. New York, NY: Wiley-Liss; 1999:637-668.
22. Cheng HL, Wright GA. Rapid high-resolution T1 mapping by variable flip angles: accurate and precise measurement in the presence of radiofrequency field inhomogeneity. Magn Reson Med. 2006;55:566-574. (Pubitemid 43352555)
23. Christensen KA, Grant DM, Schulman EM, et al. Optimal determination of relaxation-times of Fourier-transform nuclear magnetic-resonance-determination of spin-lattice relaxation-times in chemically polarized species. J Phys Chem. 1974;78:1971-1977.
24. Sourbron S, Ingrisch M, Siefert A, et al. Quantification of cerebral blood flow, cerebral blood volume, and blood-brain-barrier leakage with DCE-MRI. Magn Reson Med. 2009;62:205-217.
25. Wang MS, Haynor DR, Wilson GJ, et al. Maximizing contrast-to-noise ratio in ultra-high resolution peripheral MR angiography using a blood pool agent and parallel imaging. J Magn Reson Imaging. 2007;26:580-588. (Pubitemid 350194579)
26. Vasbinder GB, Maki JH, Nijenhuis RJ, et al. Motion of the distal renal artery during three-dimensional contrast-enhanced breath-hold MRA. J Magn Reson Imaging. 2002;16:685-696. (Pubitemid 35375567)
27. Blaimer M, Breuer F, Mueller M, et al. SMASH, SENSE, PILS, GRAPPA: how to choose the optimal method. Top Magn Reson Imaging. 2004;15:223-236. (Pubitemid 39336906)
28. Pelc NJ Optimization of flip angle for T1 dependent contrast in MRI. Magn Reson Med. 1993;29:695-699.